On August 13, Oklo Inc. rose 5.14% in regular trading, trading at $47.36/share, with turnover of $279 million. The advance reflects continued investor enthusiasm following the company's dual milestones of achieving first-ever quarterly revenue and its Groves Isotope Test Reactor reaching criticality.
Oklo reported Q2 revenue of $1.21 million, significantly beating the analyst consensus estimate of $126,250, marking the company's first recorded revenue since inception. The U.S. Department of Energy confirmed that Oklo's small modular reactor achieved criticality status on August 5, validating the company's reactor design and construction capabilities. Additionally, Oklo advanced its Aurora reactor development, expanded AI data center energy partnerships, and secured key regulatory approvals including DOE authorization for its Groves reactor startup.
Despite the wider-than-expected Q2 loss of $0.28 per share versus the $0.16 consensus estimate, the company holds approximately $3 billion in cash and securities to fund continued commercialization. The stock had previously pulled back following analyst forecast cuts and insider selling disclosures, but appears to be recovering as investors refocus on the long-term commercial potential of the company's advanced fission technology.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments